INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹241 Cr | ₹280 Cr | ₹23 Cr | ₹-44 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | ₹-30 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -13.91 | |
| Mar2024 | ₹280 Cr | 1,129.76 | |
| Mar2023 | ₹23 Cr | Positive | |
| Mar2022 | ₹-44 Cr | Negative | |
| Mar2021 | ₹-30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,083.7 Cr | 0.6% | -5.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 0.6% |
-5.1% |
-25.9% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses